0000902664-21-002564.txt : 20210503 0000902664-21-002564.hdr.sgml : 20210503 20210503170154 ACCESSION NUMBER: 0000902664-21-002564 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20210503 DATE AS OF CHANGE: 20210503 EFFECTIVENESS DATE: 20210503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avoro Life Sciences Offshore Fund Ltd. CENTRAL INDEX KEY: 0001498990 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-146407 FILM NUMBER: 21884482 BUSINESS ADDRESS: STREET 1: 110 GREENE STREET STREET 2: SUITE 800 CITY: NEW YORK STATE: NY ZIP: 10012 BUSINESS PHONE: (212) 937-4975 MAIL ADDRESS: STREET 1: 110 GREENE STREET STREET 2: SUITE 800 CITY: NEW YORK STATE: NY ZIP: 10012 FORMER COMPANY: FORMER CONFORMED NAME: venBio Select Fund Ltd. DATE OF NAME CHANGE: 20100812 D/A 1 primary_doc.xml X0708 D/A LIVE 0001498990 Avoro Life Sciences Offshore Fund Ltd. 110 GREENE STREET SUITE 800 NEW YORK NY NEW YORK 10012 (212) 937-4975 CAYMAN ISLANDS None venBio Select Fund Ltd. Other Cayman Islands Exempted Company true - Avoro Capital Advisors LLC 110 Greene Street Suite 800 New York NY NEW YORK 10012 Promoter Investment Manager of the Issuer Behzad Aghazadeh 110 Greene Street Suite 800 New York NY NEW YORK 10012 Executive Officer Portfolio Manager and Managing Partner of Avoro Capital Advisors LLC Scott Epstein 110 Greene Street Suite 800 New York NY NEW YORK 10012 Executive Officer CFO & CCO of Avoro Capital Advisors LLC - Avoro Capital GP, LLC 110 Greene Street Suite 800 New York NY NEW YORK 10012 Promoter General Partner of Avoro Capital L.P. - Avoro Capital L.P. 110 Greene Street Suite 800 New York NY NEW YORK 10012 Promoter Direct owner of Avoro Capital Advisors LLC Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000902664-20-001985 2010-07-01 true true false 1000000 Far Hills Group LLC 32243 None None 1180 AVENUE OF THE AMERICAS 18TH FLOOR NEW YORK NY NEW YORK 10036 AL ALABAMA AK ALASKA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA HI HAWAII ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA ME MAINE MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI MT MONTANA NE NEBRASKA NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN WY WYOMING false Direct Access Partners, LLC 120950 None None 40 WALL STREET 42ND FLOOR NEW YORK NY NEW YORK 10005 true Indefinite 1084074025 Indefinite false 185 44482173 true 0 true 0 Issuer's investment manager and its principals receive a management fee based on the value of the issuer's assets and/or a performance allocation based on the issuer's profits, calculated per the offering documents; includes proceeds from a master fund. false Avoro Life Sciences Offshore Fund Ltd. /s/ Scott Epstein Scott Epstein CCO and CFO of Avoro Capital Advisors LLC 2021-05-03